Alan Shortall is the Founder, Chief Executive Officer and Executive Director of Unilife Corporation, a U.S.-based medical device and technology company that designs, develops, manufactures and supplies differentiated delivery systems for injectable drugs and vaccines. Since 2002, Mr. Shortall has led the growth of the company’s products into a diversified portfolio of drug-delivery systems. He spearheaded the transition of the Australia-founded company into a registered U.S. business listed on the Nasdaq. It continues to be traded on the Australian Stock Exchange. He has overseen the construction of a 165,000-square-foot headquarters, R&D and manufacturing facility in York, Pa. In 2008, Mr. Shortall was named to the list of 100 Notable People in the medical device industry by trade magazine Medical Device and Diagnostic Industry. In January 2010, he was profiled in Drug Delivery Technology magazine.
